Direktorat Registrasi ObatValid

PANTOPRAZOLE SODIUM SESQUIHYDRATE

Claim this product
BPOM Number
GKL1413709444A1
Approved
30 March 2026
Expiry
1 February 2029
Form
SERBUK INJEKSI

About This Registration

PANTOPRAZOLE SODIUM SESQUIHYDRATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1413709444A1. Its current registration status is Valid, with the licence valid until 1 February 2029. The product is registered to MAHAKAM BETA FARMA - INDONESIA. BPOM first approved this registration in March 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
newaero
Packaging
DUS, 10 VIAL @ 40 MG
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (2)

KOMBINASI-PANTOPRAZOLE SODIUM SESQUIHYDRATE (LYOPHILIZED)PANTOPRAZOLE SODIUM SESQUIHYDRATE (LYOPHILIZED)

Market Intelligence

Owner Portfolio
MAHAKAM BETA FARMA - INDONESIA holds 146 BPOM registrations
Manufacturer Scale
MAHAKAM BETA FARMA - INDONESIA produces 146 registered products
Registration Age
Registered for 4 months

FDA Cross-Reference

via openFDA
Generic Name
PANTOPRAZOLE SODIUM
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAVENOUS

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1